REVVITY, INC.
For the period ended Sep 28, 2025. Filed Nov 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 28, 2025 · Filed Nov 4, 2025
RVTY$159.10-1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended | ||
|---|---|---|
| September 28,2025 | September 29,2024 | |
| (In thousands) | ||
| Operating activities: | ||
| Net income | $142,837 | $175,740 |
| Loss from discontinued operations, net of income taxes | 1,275 | 18,948 |
| Income from continuing operations | 144,112 | 194,688 |
| Adjustments to reconcile income from continuing operations to net cash provided by continuing operations: | ||
| Stock-based compensation | 26,918 | 32,756 |
| Restructuring and other costs, net | 24,368 | 22,119 |
| Depreciation and amortization | 302,261 | 322,816 |
| Change in fair value of contingent consideration | (59) | 6,006 |
| Amortization of deferred debt financing costs and accretion of discounts | 3,560 | 5,051 |
| Change in fair value of investments | 3,484 | (13,975) |
| Unrealized foreign exchange loss (gain) | 222 | (1,063) |
| Changes in assets and liabilities which provided (used) cash: | ||
| Accounts receivable, net | (41,643) | 33,291 |
| Inventories | 12,493 | 26,817 |
| Accounts payable | 270 | (24,782) |
| Accrued expenses and other | (68,990) | (114,236) |
| Net cash provided by operating activities of continuing operations | 406,996 | 489,488 |
| Net cash used in operating activities of discontinued operations | (6,023) | (35,419) |
| Net cash provided by operating activities | 400,973 | 454,069 |
| Investing activities: | ||
| Capital expenditures | (53,351) | (62,194) |
| Purchases of investments and notes receivables | (29) | (4,337) |
| Proceeds from investments and notes receivables | — | 2,500 |
| Proceeds from marketable securities | — | 710,000 |
| Proceeds from disposition of businesses and assets | 229 | — |
| Net cash (used in) provided by investing activities of continuing operations | (53,151) | 645,969 |
| Net cash provided by investing activities of discontinued operations | 56,250 | 147,522 |
| Net cash provided by investing activities | 3,099 | 793,491 |
| Financing activities: | ||
| Payments of senior unsecured notes | — | (711,479) |
| Payments of debt financing issuance costs | (2,474) | — |
| Payments of other credit facilities | (158) | (10,771) |
| Payments for acquisition-related contingent consideration | (3,838) | (8,832) |
| Proceeds from issuance of common stock under stock plans | 2,632 | 6,173 |
| Purchases of common stock | (652,530) | (184,421) |
| Dividends paid | (24,845) | (25,915) |
| Net cash used in financing activities | (681,213) | (935,245) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 45,264 | 4,120 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (231,877) | 316,435 |
|---|---|---|
| Cash, cash equivalents and restricted cash at beginning of period | 1,164,452 | 914,373 |
| Cash, cash equivalents and restricted cash at end of period | $932,575 | $1,230,808 |
| Supplemental disclosures of cash flow information | ||
| Reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total shown in the condensed consolidated statements of cash flows: | ||
| Cash and cash equivalents | $931,386 | $1,229,778 |
| Restricted cash included in other current assets | 1,189 | 1,030 |
| Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows | $932,575 | $1,230,808 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.